Literature DB >> 7827934

Proliferating cell nuclear antigen in the assessment of Barrett's mucosa.

P Gillen1, M McDermott, D Grehan, D O Hourihane, T P Hennessy.   

Abstract

Proliferating cell nuclear antigen (PCNA) expression was assessed in oesophageal epithelium from 70 patients with Barrett's oesophagus. PCNA counts were expressed in the form of a PCNA index. There were 24 patients with dysplastic epithelium, nine with regenerative atypia, 18 with benign histology and 19 with adenocarcinoma arising in Barrett's epithelium. The PCNA index of malignant tissue was significantly different from that of benign (P < 0.001) and dysplastic (P < 0.05) specimens. PCNA indices in histologically normal Barrett's epithelium adjacent to a tumour were significantly different (P < 0.001) from those in normal Barrett's epithelium with no adjacent tumour. These findings support the use of PCNA measurement in the assessment of Barrett's epithelium.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7827934     DOI: 10.1002/bjs.1800811219

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  9 in total

Review 1.  Molecular biology of Barrett's adenocarcinoma.

Authors:  B P Wijnhoven; H W Tilanus; W N Dinjens
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

Review 2.  Early events during neoplastic progression in Barrett's esophagus.

Authors:  Brian J Reid
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

3.  Cell cycle phase abnormalities do not account for disordered proliferation in Barrett's carcinogenesis.

Authors:  Pierre Lao-Sirieix; Rebecca Brais; Laurence Lovat; Nicholas Coleman; Rebecca C Fitzgerald
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

4.  Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model.

Authors:  R C Fitzgerald; M B Omary; G Triadafilopoulos
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

5.  Predicting Neoplastic Progression in Barrett's Esophagus.

Authors:  Jean S Wang; Marcia I Canto
Journal:  Ann Gastroentol Hepatol       Date:  2010-06

6.  Expression of p53, PCNA, and C-erbB-2 in Barrett's metaplasia and adenocarcinoma.

Authors:  R Kim; M R Clarke; M F Melhem; M A Young; M M Vanbibber; A V Safatle-Ribeiro; U Ribeiro; J C Reynolds
Journal:  Dig Dis Sci       Date:  1997-12       Impact factor: 3.199

7.  Expressions of PCNA, p53, p21(WAF-1) and cell proliferation in fetal esophageal epithelia: comparative study with adult esophageal lesions from subjects at high-incidence area for esophageal cancer in Henan, North China.

Authors:  Ying Xing; Yu Ning; Li-Qiang Ru; Li-Dong Wang
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

8.  Biomarkers in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma.

Authors:  L J Williams; D L Guernsey; A G Casson
Journal:  Curr Oncol       Date:  2006-02       Impact factor: 3.677

9.  Barrett's oesophagus and adenocarcinoma.

Authors:  Christine P J Caygill; Anthony Watson; Pierre Lao-Sirieix; Rebecca C Fitzgerald
Journal:  World J Surg Oncol       Date:  2004-05-07       Impact factor: 2.754

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.